Conclusion:Participants randomised in BaxAsia were representative of adults primarily from Asia with uHTN or rHTN with elevated SBP despite multiple antihypertensive medications.A history of dyslipidaemia, type 2 diabetes and/or obesity were the most common comorbidities.BaxAsia will assess the seated office blood pressurelowering effect and safety of baxdrostat in the study participants.I have potential conflict of interest to disclose.Participation in advisory council/committees for
Kitpermkiat et al. (Wed,) studied this question.